In the week of August 10, 2026, the capital landscape for revenue cycle management (RCM) showcases a strong trend towards innovation and technology integration, particularly in the realm of artificial intelligence. With QuantHealth's recent $45 million Series B funding aimed at enhancing AI-driven clinical trial simulations, it's clear that investors are prioritizing solutions that streamline processes and improve efficiency in healthcare delivery. This focus on tech-driven advancements indicates a broader commitment to transforming RCM practices through smart, data-driven tools.
Fierce Healthcare
QuantHealth has secured $45 million in a Series B funding round to enhance its AI-driven clinical trial simulations. The company intends to use the funds for research and development, team expansion, and product portfolio growth, according to CEO Orr Inbar. This investment reflects a growing interest in AI technologies within the revenue cycle management (RCM) sector, potentially accelerating innovation and efficiency in clinical trials.
Source →Every deal, every week
Subscribe to the RevCycleAI newsletter. Free weekly RCM intelligence — deals, payer moves, and vendor deep dives.
Subscribe Free →